Transplantation of co-microencapsulated hepatocytes and HUVECs for treatment of fulminant hepatic failure

被引:11
作者
Qiu, Liyuan [1 ,2 ]
Wang, Jian [3 ]
Wen, Xinyu [4 ]
Wang, Haibin [1 ,2 ]
Wang, Yan [1 ,2 ]
Lin, Qiuxia [1 ,2 ]
Du, Zhiyan [1 ,2 ]
Duan, Cuimi [1 ,2 ]
Wang, Chunren [3 ]
Wang, Changyong [1 ,2 ]
机构
[1] Acad Mil Med Sci, Inst Basic Med Sci, Dept Adv Interdisciplinary Studies, Beijing 100850, Peoples R China
[2] Acad Mil Med Sci, Tissue Engn Res Ctr, Beijing 100850, Peoples R China
[3] Natl Inst Control Pharmaceut & Biol Prod, Beijing, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, Beijing, Peoples R China
关键词
Co-microencapsulated; FHF; Hepatocyte; HUVEC; Transplantation; MARROW STEM-CELLS; LIVER-FAILURE; INTRASPLENIC TRANSPLANTATION; PORCINE HEPATOCYTES; ENDOTHELIAL-CELLS; IMPROVED SURVIVAL; RATS; ISLETS; COENCAPSULATION; HEPATECTOMY;
D O I
10.5301/ijao.5000092
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Purpose: Microencapsulated hepatocytes might solve immunological rejection, broadening a new perspective for the treatment of fulminant hepatic failure (FHF). However, the transplantation of microcapsulated hepatocytes is limited by low cell viability. Nevertheless, the.co-microencapsulation of hepatocytes and human umbilical vein endothelial cells (HUVECs) may make the treatment of FHF more promising. Methods: We prepared the microcapsules using the high-voltage electrostatic droplet spray method, transplanted the empty microcapsules, isolated hepatocytes, microcapsulated hepatocytes, and co-microencapsulated hepatocytes and HUVEC intraperitoneally into rat models of FHF induced by D-aminogalactose (D-gal). After 1, 3, and 7 days, and 2, 3, and 4 weeks posttransplantation, we calculated the mortality and assessed alanine aminotransferase (ALT), aspartate aminotransferase (AST), and albumin (ALB) levels in the serum of the model; evaluated the integrality and recovery of microcapsules; and stained with hematoxylin and eosin (H&E) the recovered microcapsules as well as the liver of the FHF rats. Results: Hepatocyte-specific functions, including the levels of ALT, AST and ALB in the serum of the co-microencapsulation group, were significantly better than those in the other groups (p < 0.05) from 2 to 4 weeks after transplantation. Moreover, cotransplantation of the microencapsulated hepatocytes and HUVECs decreased the mortality rate of the FHF rats. The recovered microcapsules were intact, and recovery was up to 90%. H&E staining showed that the microencapsulated cells were still alive, and the liver tissues had started to recover after 4 weeks posttransplantation. Conclusion: The microcapsules have good biocompatibility and immunoprotection to protect the hepatocytes from immunological rejection. Cotransplantation of the microencapsulated hepatocytes and HUVECs could decrease mortality rates and improve liver function in FHF
引用
收藏
页码:458 / 465
页数:8
相关论文
共 44 条
  • [31] Multisorbent plasma perfusion in fulminant hepatic failure: Effects of duration and frequency of treatment in rats with Grade III hepatic coma
    Ryan, CJ
    Anilkumar, T
    Ben-Hamida, AJA
    Khorsandi, SE
    Aslam, M
    Pusey, CD
    Gaylor, JDS
    Courtney, JM
    ARTIFICIAL ORGANS, 2001, 25 (02) : 109 - 118
  • [32] Successful liver transplantation for indomethasine induced fulminant hepatic failure in adult Still's disease:: Case report
    Soemez, Alper
    Dogru, Teoman
    Tasci, Ilker
    Mas, Mehmet Refik
    Yelmaz, Sedat
    Yagci, Goekhan
    Cetiner, Sadettin
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2007, 27 (05): : 788 - 790
  • [33] Hepatic encephalopathy: current management strategies and treatment, including management and monitoring of cerebral edema and intracranial hypertension in fulminant hepatic failure
    Zafirova, Zdravka
    O'Connor, Michael
    CURRENT OPINION IN ANESTHESIOLOGY, 2010, 23 (02) : 121 - 127
  • [34] High metabolic function of primary human and porcine hepatocytes in a polyurethane foam/spheroid culture system in plasma from patients with fulminant hepatic failure
    Yamashita, Y
    Shimada, M
    Tsujita, E
    Shirabe, K
    Ijima, H
    Nakazawa, K
    Sakiyama, R
    Fukuda, J
    Funatsu, K
    Sugimachi, K
    CELL TRANSPLANTATION, 2002, 11 (04) : 379 - 384
  • [35] Delayed Fulminant Hepatic Failure from Dydrogesterone-Related In Vitro Fertilization Therapy Requiring Liver Transplantation During Pregnancy
    Malherbe, Jacques A. J.
    Garas, George
    Khor, Tze S.
    MacQuillan, Gerry C.
    AMERICAN JOURNAL OF CASE REPORTS, 2020, 21 : 1 - 7
  • [36] Liver Transplantation Treating the Patient with Hepatic Failure Associated with Sorafenib Treatment: Report of a Case
    Rao, Jianhua
    Feng, Min
    Qian, Xiaofeng
    Li, Guoqiang
    Wang, Xuehao
    Zhang, Feng
    Lu, Ling
    HEPATO-GASTROENTEROLOGY, 2013, 60 (126) : 1317 - 1319
  • [37] Fulminant hepatic failure secondary to acetaminophen poisoning: A systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation
    Bailey, B
    Amre, DK
    Gaudreault, P
    CRITICAL CARE MEDICINE, 2003, 31 (01) : 299 - 305
  • [38] Bioartificial liver treatment in rats with fulminant hepatic failure: Effect on DNA-binding activity of liver-enriched and growth-associated transcription factors
    Suh, KS
    Lilja, H
    Kamohara, Y
    Eguchi, S
    Arkadopoulos, N
    Neuman, T
    Demetriou, AA
    Rozga, J
    JOURNAL OF SURGICAL RESEARCH, 1999, 85 (02) : 243 - 250
  • [39] Orthotopic liver transplantation for subacute hepatic failure following partial treatment of isoniazid-resistant tuberculosis
    Nash, K. L.
    Yeung, T. M.
    Lehner, P. J.
    Gibbs, P.
    Griffiths, W. J. H.
    TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (04) : 272 - 275
  • [40] ENCAPSULATED HEPATOCYTE TRANSPLANTATION FOR THE TREATMENT OF D-GALACTOSAMINE-INDUCED ACUTE HEPATIC-FAILURE IN RATS
    HIRAI, S
    KASAI, S
    MITO, M
    EUROPEAN SURGICAL RESEARCH, 1993, 25 (04) : 193 - 202